Cipla500087Government probe
DRI conducts search at Vikhroli office and Bhiwandi depot; company says no material impact
DRI, Mumbai zonal unit, conducted a search under the Customs Act, 1962 at the company's Vikhroli office and Bhiwandi depot on 16 November 2026; it concluded the same day.
By ScoutQuest · · 2 min read
- Authority / Action
- DRI, Mumbai zonal unit, search under Section 105 of the Customs Act, 1962
- Search Date
- 16 November 2026 (initiated and concluded the same day)
- Locations Searched
- Vikhroli office, Mumbai and Bhiwandi depot, Thane
What the update says
- The company notified the exchanges that the Directorate of Revenue Intelligence (DRI), Mumbai zonal unit, conducted a search proceeding on 16 November 2026.
- Two locations are named: the company's office in Vikhroli, Mumbai, Maharashtra, and its depot in Bhiwandi, Thane, Maharashtra.
- The action is described as the initiation of a search under Section 105 of the Customs Act, 1962.
- The search was initiated on 16 November 2026 and concluded on the same day.
- The company said it extended its full co-operation and assistance.
What the search relates to
- The stated subject is the classification / exemption of an imported pharmaceutical finished product.
- In plain terms, this points to a question over how an imported finished medicine was classified for customs purposes, or which exemption was applied to it.
- The update links the search to that classification / exemption question and does not attach any monetary figure to it.
The company's stated impact
- Against the head "Impact on financial, operation or other activities", the company has stated: "There is no material impact on the Company's financials, operations or other activities, due to the said search."
- That is the company's own assessment, given in the disclosure itself.
How a retail investor might read this
- A search proceeding by a revenue-intelligence authority at company premises is an event that draws attention, and the company has disclosed it to the exchanges.
- Alongside that, the company has put its own view on record that the impact is not material to financials, operations or other activities.
- The subject is described as a classification / exemption matter concerning one imported pharmaceutical finished product, and the search itself began and concluded on the same day.
Points the update records
- The authority: Directorate of Revenue Intelligence, Mumbai zonal unit.
- The action: initiation of a search under Section 105 of the Customs Act, 1962.
- The dates: initiated and concluded on 16 November 2026.
- The subject: classification / exemption of an imported pharmaceutical finished product.
- The company's impact statement: no material impact on financials, operations or other activities.
Also from Cipla
Board approves appointment of Vikram Janakiraman as Global Chief Technical Operating Officer
4 Nov 2026
Q2FY27 earnings call: revenue INR7,404 crores, EBITDA margin 18.7%, 3 more US launches lined up
30 Oct 2026
Cipla saw buy flows on the dealing desk with dealers expecting strong Q2 numbers; stock up over 5%
29 Oct 2026
Source: BSE · 16 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.